Standout Papers

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic ... 1989 2026 2001 2013 1.6k
  1. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. (1989)
    Seppo Ylä‐Herttuala, Wulf Palinski et al. Journal of Clinical Investigation
  2. Low density lipoprotein undergoes oxidative modification in vivo. (1989)
    Wulf Palinski, Michael E. Rosenfeld et al. Proceedings of the National Academy of Sciences
  3. Autoantibody against oxidised LDL and progression of carotid atherosclerosis (1992)
    J T Salonen, H Korpela et al. The Lancet
  4. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice (2000)
    Andrew C. Li, Kathleen K. Brown et al. Journal of Clinical Investigation
  5. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. (1997)
    Claudio Napoli, Francesco Paolo D’Armiento et al. Journal of Clinical Investigation
  6. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo (1997)
    Andrew D. Watson, Norbert Leitinger et al. Journal of Biological Chemistry
  7. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein (1998)
    Mercedes Ricote, Lluís Fajas et al. Proceedings of the National Academy of Sciences
  8. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL (2003)
    Christoph J. Binder, Sohvi Hörkkö et al. Nature Medicine
  9. Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice (1999)
    Karen S. Moulton, Moritz A. Konerding et al. Circulation
  10. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. (1990)
    Wulf Palinski, Seppo Ylä‐Herttuala et al. Arteriosclerosis An Official Journal of the American Heart Association Inc
  11. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity (2000)
    Peter X. Shaw, Sohvi Hörkkö et al. Journal of Clinical Investigation

Immediate Impact

3 by Nobel laureates 34 from Science/Nature 191 standout
Sub-graph 1 of 12

Citing Papers

Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
2013 StandoutScience
Hallmarks of Cancer: The Next Generation
2011 Standout
31 intermediate papers

Works of Wulf Palinski being referenced

Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
1999 Standout
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
1994
and 23 more

Author Peers

Author Last Decade Papers Cites
Wulf Palinski 9591 4816 4845 5663 115 20.6k
Judith A. Berliner 5049 3085 2826 5459 131 15.1k
Alan M. Fogelman 7134 10577 4365 8409 263 31.0k
Michael E. Rosenfeld 4947 3436 2526 3005 94 13.3k
Stephen M. Prescott 5987 4783 1325 8977 228 25.3k
Linda K. Curtiss 5756 5022 1246 4718 190 14.8k
T E Carew 3626 3953 5702 2595 47 12.9k
Sotirios Tsimikas 6884 12874 2083 4392 372 24.2k
Tatsuya Sawamura 9595 2668 1507 4472 257 17.0k
Peter A. Edwards 3249 10237 1545 11617 165 23.5k
Alan Daugherty 5347 5338 948 4779 312 20.4k

All Works

Loading papers...

Rankless by CCL
2026